Greenoaks Capital Reports a $6.8 Million CPNG Purchase

August 26, 2024

The most significant insider buy on today’s list comes via a Form 4 filing by Greenoaks Capital Partners LLC.

The investment firm reported an additional purchase of $6.8 million in Coupang Inc $CPNG.

RTW Investments LP filed a 13D for Avidity Biosciences $RNA revealing an increase in ownership from 7.45% to 9.99%.

Here’s The Hot Corner, with data from August 23, 2024:

Director Richard T. Carucci revealed an acquisition of 15,000 shares in V.F. Corporation $VFC.

In another Form 4, the CEO of Orion Engineered Carbons S.A. $OEC bought $176,900 worth in OEC shares.

After an impressive rally off the all-time lows, RNA has been coiling in a tight range above its IPO level, digesting some of its gains.

The line in the sand lies at the 37 level.

If we're above 37, the path of least resistance is higher for RNA.

Stay tuned. We'll be back on Tuesday with more insider activity.

For questions about your membership, contact us at 323-421-7910 or info@stockmarketmedia.com

Filed Under: